I71.0 I71.1 I71.2 I71.3 I71.4
Conditions
Interventions
Group 1: Patients with a Percutek thoracic stent graft system are followed up for 2 years as part of standard care. Depending on availability, data collected includes surgical procedure information (p
Sponsors
Klinikum Chemnitz gGmbH
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Planned or emergency implantation of a Percutek abdominal or thoracic stent graft prosthesis as part of routine care. The indication is determined in accordance with current guidelines, regardless of study participation. Minimum age of 18 years The patient’s ability to provide written consent The patient’s willingness to participate in follow-up examinations
Exclusion criteria
Exclusion criteria: Contraindications as specified in the Instructions for Use (IFU) or other medical, social, or psychological issues that, in the investigator’s judgment, preclude the patient from participating in the treatment as well as the pre- and post-procedure procedures and assessments. The patient is unwilling or unable to comply with the study’s follow-up examinations
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Aortic-related mortality (death from aortic-specific causes) is recorded and documented through follow-up contacts throughout the entire 2-year follow-up period. | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall mortality, technical success, composite clinical success | — |
Countries
Germany
Contacts
Public ContactSven Seifert
Klinikum Chemnitz gGmbH
Outcome results
None listed